Selecta Biosciences, Inc. (SELB) Social Stream
SELECTA BIOSCIENCES INC (SELB) Price Targets From Analysts
Use the tables below to see what analysts covering SELECTA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-01-11 | 5 | $10 | $6 | $8 | $0.958 | 735.07% |
2022-03-11 | 5 | $10 | $6 | $7.75 | $0.958 | 708.98% |
2022-05-06 | 4 | $10 | $6 | $7.25 | $0.958 | 656.78% |
2022-06-06 | 6 | $10 | $6 | $7.2 | $0.958 | 651.57% |
2022-06-14 | 6 | $7 | $5 | $6 | $0.958 | 526.3% |
2023-01-13 | 5 | $7 | $4 | $5.5 | $0.958 | 474.11% |
2023-03-07 | 5 | $9 | $4 | $6.2 | $0.958 | 547.18% |
2023-04-13 | 6 | $9 | $4 | $6.166 | $0.958 | 543.63% |
2023-05-08 | 6 | $5 | $4 | $4.666 | $0.958 | 387.06% |
2023-08-18 | 6 | $5 | $3 | $4.5 | $0.958 | 369.73% |
The Trend in the Analyst Price Target
Over the past 52 weeks, SELB's average price target has gone down $1.
SELB reports an average of 314.87% for its upside potential over the past 35 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-01-13 | 6 | 7 | 4 | 5.500 | 1.69 | 225.44% |
2023-04-05 | 6 | 9 | 4 | 6.166 | 1.30 | 374.31% |
2023-05-05 | 6 | 9 | 4 | 5.833 | 1.08 | 440.09% |
2023-05-08 | 6 | 5 | 4 | 4.666 | 1.19 | 292.1% |
2023-08-18 | 6 | 5 | 3 | 4.500 | 1.13 | 298.23% |
SELB Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.5 | 4 | 1 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
SELB's average broker recommendation rating improved by 0.25 over the prior 24 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SELB has a greater average analyst price target than 100.88% of all US stocks.
- SELB has a higher upside potential (average analyst target price relative to current price) than 1659.98% of all US stocks.
- In the context of Healthcare stocks, SELECTA BIOSCIENCES INC's number of analysts covering the stock is higher than 566.84% of them.
- In terms of how SELECTA BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1034.36% of that group.
In the Pharmaceutical Products industry, ACIU, SNDX, and NEPT are the three stocks most similar to SELECTA BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for SELB? Use POWR Ratings for clearer insight into price direction.